ABILITY TO PAY AND WILLINGNESS TO PAY FOR COVID-19 VACCINATION: ARE WE READY?

  • Amirah Azzeri Public Health Unit, Department of Primary Care, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia
  • Nur Amina Abdul Laziz Public Health Unit, Department of Primary Care, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia
  • Muslimah Ithnin Public Health Unit, Department of Primary Health Care, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia
  • Hafiz Jaafar Public Health Unit, Department of Primary Health Care, Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia
Keywords: Ability to pay (ATP), Willingness to pay (WTP), Vaccine, Financial COVID-19

Abstract

Vaccinations were considered to be among the most effective way in preventing further COVID-19 transmission. To date, the manufactures of vaccines were in the third phase of clinical trial studies. However, the extent to which the publics are able to pay and willing to pay for this vaccine remains unclear. This study aimed to evaluate the ability to pay (ATP) and willingness to pay (WTP) for COVID-19 vaccination in Malaysia. A cross sectional study was conducted among 67 staff of a public university in Nilai, Negeri Sembilan. The ATP and WTP were obtained through an open and close-ended method via either face-to-face interview or telephone-based interview. For the open-ended method, the mean (SD) ATP and WTP values recorded were USD 52.35 (620.83) and USD 52.08 (620.82) respectively. As for the close-ended, the mean (SD) ATP and WTP values recorded were USD 52.08 (620.82) and USD 32.38 (147.97) respectively. Through closed-ended method, lower ATP and WTP values were recorded compared with open-ended method, as the respondents are able to negotiate through a bidding process to get the best price of vaccine. Female, Malay, married, permanent staff and respondents with side-income respondents recorded higher ATP and WTP values in open-ended method. Nevertheless, except for the side-income, other factors in this study were not statistically significant. Findings from this study could facilitate government to set appropriate market price to ensure the affordability of COVID-19 vaccine and improve its accessibility so that a big proportion of the people will be vaccinated and protected from this disease.

References

Acuti Martellucci C, Flacco ME, Cappadona R, Bravi F, Mantovani L, Manzoli L. SARS-CoV-2 pandemic: An overview. Adv Biol Regul [Internet]. Elsevier Ltd; 2020 Aug 1 [cited 2020 Nov 28];77. Available from: https://doi.org/10.1016/j.jbior.2020.100736

World Health Organization. WHO announces COVID-19 outbreak. 2020.

Jaafar H, Azzeri A. Winning The War Against Covid-19 in Malaysia : An Achievable Goal? Malaysian J Public Heal Med. 2020;20(1):148–9.

Azzeri A, Jaafar H, Dahlui M, Othman S, Tunku Kamarul Z. Prediction of diseases burden and healthcare resource utilization through simple predictive analytics using mathematical approaches, an experience from University of Malaya Medical Centre. J Univ Malaya Med Cent. 2020;1(3):10–5.

Ministry of Health Malaysia. Current situation of COVID-19 pandemic in Malaysia [Internet]. 2020 [cited 2021 Jan 13]. Available from: http://covid-19.moh.gov.my/

Elengoe A. COVID-19 outbreak in Malaysia [Internet]. Osong Public Health and Research Perspectives. Korean Disease Control and Prevention Agency; 2020 [cited 2021 Feb 1]. p. 93–100. Available from: https://doi.org/10.24171/j.phrp.2020.11.3.08

Shah AUM, Safri SNA, Thevadas R, Noordin NK, Rahman AA, Sekawi Z, et al. COVID-19 outbreak in Malaysia: Actions taken by the Malaysian government. Int J Infect Dis [Internet]. Elsevier B.V.; 2020 Aug 1 [cited 2020 Nov 28];97:108–16. Available from: https://pubmed.ncbi.nlm.nih.gov/32497808/

Albitar O, Ballouze R, Ooi JP, Maisharah S, Ghadzi S. Risk factors for mortality among COVID-19 patients. [cited 2020 Nov 29]; Available from: https://doi.org/10.1016/j.diabres.2020.108293

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. Lancet Publishing Group; 2020 Feb 15 [cited 2021 Feb 1];395(10223):497–506. Available from: https://isaric.tghn.org/protocols/

Manivannan M, Jogalekar MP, Kavitha MS, Maran BAV, Gangadaran P. A mini-review on the effects of COVID-19 on younger individuals [Internet]. Experimental Biology and Medicine. SAGE Publications Inc.; 2020 [cited 2020 Nov 28]. Available from: https://pubmed.ncbi.nlm.nih.gov/33210552/

Lim Heng Sim B, Kumar Chidambaram S, Ci Wong X, Dass Pathmanathan M, Peariasamy KM, Peng Hor C, et al. Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ). Lancet Reg Heal Pacific [Internet]. 2020 [cited 2020 Nov 29];4:55. Available from: https://doi.org/10.1016/j.lanwpc.2020.10

Singhal T. A Review of Coronavirus Disease-2019 (COVID-19) [Internet]. Indian Journal of Pediatrics. Springer; 2020 [cited 2021 Feb 1]. p. 281–6. Available from: https://doi.org/10.1007/s12098-020-03263-6

Ganasegeran K, Ch’ng ASH, Looi I. COVID-19 in Malaysia: Crucial measures in critical times. Journal of global health. NLM (Medline); 2020. p. 20333.

Alsayed A, Sadir H, Kamil R, Sari H. Prediction of epidemic peak and infected cases for COVID-19 disease in Malaysia. Int J Environ Res Public Health [Internet]. MDPI AG; 2020 Jun 1 [cited 2020 Nov 28];17(11):1–15. Available from: https://pubmed.ncbi.nlm.nih.gov/32521641/

Singh S, Sundram BM, Rajendran K, Law KB, Aris T, Ibrahim H, et al. Forecasting daily confirmed COVID-19 cases in Malaysia using ARIMA models. J Infect Dev Ctries [Internet]. Journal of Infection in Developing Countries; 2020 Sep 1 [cited 2020 Nov 28];14(9):971–6. Available from: https://pubmed.ncbi.nlm.nih.gov/33031083/

Rampal L. COVID-19 pandemic update. Med J Malaysia. 2020;75(3):195.

Wong LP, Alias H. Temporal changes in psychobehavioural responses during the early phase of the COVID-19 pandemic in Malaysia. J Behav Med [Internet]. Springer; 2020 [cited 2020 Nov 28]; Available from: https://pubmed.ncbi.nlm.nih.gov/32757088/

Kalok A, Sharip S, Hafizz AMA, Zainuddin ZM, Shafiee MN. The psychological impact of movement restriction during the COVID-19 outbreak on clinical undergraduates: A cross-sectional study. Int J Environ Res Public Health [Internet]. MDPI AG; 2020 Nov 2 [cited 2020 Nov 28];17(22):1–13. Available from: https://pubmed.ncbi.nlm.nih.gov/33212969/

Azlan AA, Hamzah MR, Sern TJ, Ayub SH, Mohamad E. Public knowledge, attitudes and practices towards COVID-19: A cross-sectional study in Malaysia. PLoS One. 2020;15(5):1–15.

Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother [Internet]. Taylor & Francis; 2020;16(9):2204–14. Available from: https://doi.org/10.1080/21645515.2020.1790279

Halloran ME, Longini IM, Struchiner CJ. Design and analysis of vaccine studies [Internet]. New York, NY: Springer New York; 2010 [cited 2021 Feb 1]. Available from: http://link.springer.com/10.1007/978-0-387-68636-3

Sarasty O, Carpio CE, Hudson D, Guerrero-Ochoa PA, Borja I. The demand for a COVID-19 vaccine in Ecuador. Vaccine. 2020. p. 8090–8.

García LY, Cerda AA. Contingent assessment of the COVID-19 vaccine. Vaccine. 2020. p. 5424–9.

Dong D, Xu RH, Wong EL yi, Hung CT, Feng D, Feng Z, et al. Public preference for COVID-19 vaccines in China: A discrete choice experiment. Heal Expect. 2020;23(6):1543–78.

Muqattash R, Niankara I, Traoret RI. Survey data for COVID-19 vaccine preference analysis in the United Arab Emirates. Data in Brief. 2020.

Trudeau JM, Alicea-Planas J, Vásquez WF. The value of COVID-19 tests in Latin America. Economics and Human Biology. 2020.

Echazu L, Nocetti DC. Willingness to pay for morbidity and mortality risk reductions during an epidemic. Theory and preliminary evidence from COVID-19. GENEVA Risk and Insurance Review. 2020. p. 114–33.

Ezat S, Puteh W. Willingness to Pay for Drugs in Future National Health Financing Scheme among Malaysian Population. 2016;(January 2014).

Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, et al. Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum Vaccines Immunother [Internet]. Taylor & Francis; 2020;16(12):3074–80. Available from: https://doi.org/10.1080/21645515.2020.1819741

Berghea F, Berghea CE, Abobului M, Vlad VM. Willingness to Pay for a for a Potential Vaccine Against SARS-CoV-2 / COVID-19 Among Adult Persons. 2020;1–11.

Azzeri A, Shabaruddin F, Jaafar H, Mohamed R, Dahlui M. Out-of-Pocket Healthcare Expenditure in Various Household Income Groups Among Patients with Hepatitis C Disease Stages: Findings from. Value in Health Regional Issues [Internet]. 2018 [cited 2021 Apr 17]. p. S147. Available from: https://www.valuehealthregionalissues.com/article/S2212-1099(20)30347-2/abstract

Gallagher J. Covid vaccine update: when will others be ready? BBC News. 2020.

MyMetro. Malaysia tunggu keberkesanan vaksin Covid-19 [Internet]. Harian Metro. 2020 [cited 2021 Feb 1]. Available from: https://www.hmetro.com.my/mutakhir/2020/12/648660/malaysia-tunggu-keberkesanan-vaksin-covid-19-metrotv

Lee HY, Lee J, Kim NK. Gender Differences in Health Literacy Among Korean Adults: Do Women Have a Higher Level of Health Literacy Than Men? Am J Mens Health [Internet]. SAGE Publications Inc.; 2015 Sep 13 [cited 2021 Feb 3];9(5):370–9. Available from: http://journals.sagepub.com/doi/10.1177/1557988314545485

Published
2021-04-24
How to Cite
Azzeri, A., Abdul Laziz, N. A., Ithnin, M., & Jaafar, H. (2021). ABILITY TO PAY AND WILLINGNESS TO PAY FOR COVID-19 VACCINATION: ARE WE READY?. Malaysian Journal of Public Health Medicine, 21(1), 347-355. https://doi.org/10.37268/mjphm/vol.21/no.1/art.1006